We first determined whether CREB3L2-ATF4 was found in the human brain and to what extent its heterodimerization levels were different in AD by performing coimmunoprecipitation in samples of nondemented control and disease cases (table S1). This evidence concerns the gene CREB3L2 and Alzheimer disease.